Susanna Naggie, MD

Professor of Medicine
Vice Dean for Clinical Research
Member in the Duke Clinical Research Institute
Campus mail 300 West Morgan St, Suite 800, Durham, NC 27701
Phone (919) 684-2584
Email address susanna.naggie@duke.edu

Dr. Susanna Naggie completed her medical education at Johns Hopkins School of Medicine and her internal medicine training at Duke University Medical Center (DUMC), where she also served as a Chief Resident in Internal Medicine.  She completed her Infectious Diseases (ID) fellowship training at Duke and then joined the faculty in the Division of ID. She is an Associate Professor of Medicine with Tenure and currently holds joint appointments at the Duke Clinical Research Institute (DCRI, Director of ID Research), and at the Durham Veterans Affairs Medical Center (DVAMC). Dr. Naggie has dedicated her academic career to the care of patients with HIV and viral hepatitis, with a research program focused on understanding the mechanisms of accelerated liver fibrogenesis in this population and the extrahepatic health outcomes attributed to HCV in persons with HIV infection. In addition to her investigator-initiated research program, Dr. Naggie is also involved in multiple clinical trials and clinical registries with a particular focus on HIV and liver disease. She is the prior co-Chair of the AASLD/IDSA HCV Guidance Committee and is currently Chair of the AIDS Clinical Trials Group Viral Hepatitis Transformative Science Group Committee and a member of the DHHS Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV and the CDC/NIH/IDSA-HIVMA Opportunistic Infections Guideline Committee. For the past two years Dr. Naggie has served as the Medical Director of the Duke Department of Medicine Clinical Research Unit.

Education and Training

  • Fellow in Infectious Diseases, Medicine, Duke University, 2007 - 2009
  • Chief Medical Resident - VAMC, Medicine, Duke University, 2006 - 2007
  • Medical Resident, Medicine, Duke University, 2002 - 2005
  • M.D., Johns Hopkins University, 2002

Publications

Solomon, Sunil S., Sandra Wagner-Cardoso, Laura Smeaton, Leonard A. Sowah, Chanelle Wimbish, Gregory Robbins, Irena Brates, et al. “A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial.” Lancet Gastroenterol Hepatol 7, no. 4 (April 2022): 307–17. https://doi.org/10.1016/S2468-1253(21)00397-6.

PMID
35026142
Full Text

Narayanasamy, Shanti, Ahmad Mourad, Nicholas A. Turner, Thuy Le, Robert J. Rolfe, Nwora Lance Okeke, Sean M. O’Brien, et al. “COVID-19 Trials: Who Participates and Who Benefits?” South Med J 115, no. 4 (April 2022): 256–61. https://doi.org/10.14423/SMJ.0000000000001374.

PMID
35365841
Full Text

Lake, Jordan E., Turner Overton, Susanna Naggie, Mark Sulkowski, Rohit Loomba, David E. Kleiner, Jennifer C. Price, Kara W. Chew, Raymond T. Chung, and Kathleen E. Corey. “Expert Panel Review on Nonalcoholic Fatty Liver Disease in Persons With Human Immunodeficiency Virus.” Clin Gastroenterol Hepatol 20, no. 2 (February 2022): 256–68. https://doi.org/10.1016/j.cgh.2020.10.018.

PMID
33069882
Full Text

Messina, Julia A., Eileen K. Maziarz, John Galgiani, Jonathan T. Truong, Aung K. Htoo, Arash Heidari, Royce H. Johnson, et al. “A randomized, double-blind, placebo-controlled clinical trial of fluconazole as early empiric treatment of coccidioidomycosis pneumonia (Valley Fever) in adults presenting with community-acquired pneumonia in endemic areas (FLEET-Valley Fever).” Contemp Clin Trials Commun 24 (December 2021): 100851. https://doi.org/10.1016/j.conctc.2021.100851.

PMID
34712863
Full Text

Collins, Lauren F., Anandi N. Sheth, C Christina Mehta, Susanna Naggie, Elizabeth T. Golub, Kathryn Anastos, Audrey L. French, et al. “Incident Non-AIDS Comorbidity Burden Among Women With or at Risk for Human Immunodeficiency Virus in the United States.” Clin Infect Dis 73, no. 7 (October 5, 2021): e2059–69. https://doi.org/10.1093/cid/ciaa1928.

PMID
33388773
Full Text

Friedland, Anne, Adrian F. Hernandez, Kevin J. Anstrom, Mei Lin Chen-Lim, Lauren W. Cohen, Judith S. Currier, Christopher B. Forrest, et al. “Design of the Healthcare Worker Exposure Response and Outcomes (HERO) research platform.” Contemp Clin Trials 109 (October 2021): 106525. https://doi.org/10.1016/j.cct.2021.106525.

PMID
34371163
Full Text

Naggie, Susanna, Jennifer C. Price, J Will Thompson, Joseph E. Lucas, Laura Dubois, Lisa St John-Williams, Michael Saag, et al. “VALIDATION OF A METABOLOMIC SIGNATURE AS A PREDICTOR OF END-STAGE LIVER DISEASE EVENTS IN PEOPLE WITH HIV/HCV COINFECTION.” In Hepatology, 74:559A-560A, 2021.

Scholars@Duke

Kuriakose, Safia, Kanal Singh, Alice K. Pau, Eric Daar, Rajesh Gandhi, Pablo Tebas, Laura Evans, et al. “Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19.” Ann Intern Med 174, no. 8 (August 2021): 1151–58. https://doi.org/10.7326/M21-1647.

PMID
34125574
Full Text

Fang, Ferric C., Constance A. Benson, Carlos Del Rio, Kathryn M. Edwards, Vance G. Fowler, David N. Fredricks, Ajit P. Limaye, et al. “COVID-19-Lessons Learned and Questions Remaining.” Clin Infect Dis 72, no. 12 (June 15, 2021): 2225–40. https://doi.org/10.1093/cid/ciaa1654.

PMID
33104186
Full Text

Axfors, Cathrine, Andreas M. Schmitt, Perrine Janiaud, Janneke Van’t Hooft, Sherief Abd-Elsalam, Ehab F. Abdo, Benjamin S. Abella, et al. “Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.” Nat Commun 12, no. 1 (May 14, 2021): 3001. https://doi.org/10.1038/s41467-021-23559-1.

PMID
33990619
Full Text

Pages